The Protective Role of Vitamin E Against Teratogenic Effects of Nicotine on Embryonic Bone Development

Year 2022, Volume: 4 Issue: 1, 7 - 15, 01.01.2022

Hatice Güler , Kenan Aycan Seher Yılmaz , Mehtap Nisari , Tolga Ertekin , Özge Al , Emre Atay , Halil Yılmaz , Hilal Kübra Güçlü Ekinci

https://doi.org/10.37990/medr.942726

Cited By: 1

Abstract

Aim: According to World Health Organization data, around 1.5 billion people in the world use tobacco products. Nicotine, the most common use of tobacco, is the main psychoactive substance that causes addiction. Exposure to nicotine during pregnancy increases the risk of low placenta weight, stillbirth, congenital heart disease, musculoskeletal defect. Antioxidants are used to protect against teratogenic substances such as nicotine. The purpose of the study was to determine the skeletal system malformations caused by low (3 mg/kg) and high (6 mg/kg) doses of nicotine during embryonic bone evolution by using the double skeletal staining method and the protector role of vitamin E in preventing these malformations.
Material and Method: The rats were divided into 6 groups: the control, low-dose nicotine, high-dose nicotine, low-dose nicotine+vitamin E, high-dose nicotine+vitamin E and vitamin E. The development of the skeletal system of the fetuses was examined by the skeleton staining method. The anterior and posterior extremity images of the fetuses were examined under the stereomicroscope and then through photographing total bone length, ossification length and ossification rate were calculated in the ImageJ program.
Results: There was an important decline in the total bone length, ossification length and ossification rate (p<0.05) in the bone measurements of the front and hind extremities, while it was found that the treatment groups approached the control group and the increases were important (p<0.05).
Conclusion: It was concluded that being to nicotine during pregnancy delayed skeletal ossification and that vitamin E, which is an antioxidant, may be protective opposite the teratogenic effect of nicotine on the bone.

Keywords

bone development , double skeletal staining , nicotine , rat , vitamin E

References

• Abate M, Vanni D, Pantalone A, Salini, V. 2013. Cigarette smoking and musculoskeletal disorders. Muscles Ligaments Tendons J. 3(2):63-69.
• Abukhadir SS, Mohamed N, Makpol S, Muhammad N. 2012. Effects of palm vitamin e on bone-formation-related gene expression in nicotine-treated rats. Evid Based Complement Alternat Med. 2012:656025.
• Al-Attar AM. 2011. Antioxidant effect of vitamin E treatment on some heavy metals-induced renal and testicular injuries in male mice. Saudi J Biol Sci, 18(1):63-72.
• Altun I, Yuksel KZ. 2017. An experimental study on the effects of smoking in the perinatal period and during lactation on the intervertebral disks of newborns. World Neurosurg. 99:1-5.
• Baştuğ O. 2005. The effects of taking nicotine or nicotine-pentoxifylline on bone development of pups in pregnancy and lactation [dissertation]. Kayseri: Erciyes University.
• Behnke M, Smith VC, Committee on Substance Abuse, Committee on Fetus and Newborn. 2013. Prenatal substance abuse: short- and long-term effects on the exposed fetus. Pediatrics, 131(3):e1009-24.
• Benowitz NL, Hukkanen J, Jacob P 3rd. 2009. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol. 192:29-60.
• Carmines EL, Gaworski CL, Faqi AS, Rajendran N. 2003. In utero exposure to 1R4F reference cigarette smoke: evaluation of developmental toxicity. Toxicol Sci. 75(1):134-147. Einarson A, Riordan S. 2009. Smoking in pregnancy and lactation: a review of risks and cessation strategies. Eur J Clin Pharmacol. 65(4):325-30.
• Fang Y, Svoboda KK. 2005. Nicotine inhibits human gingival fibroblast migration via modulation of Rac signalling pathways. J Clin Periodontol. 32(12):1200-1207.
• Farag MM, Selima EA, Salama MA. 2013. Impact of chronic nicotine administration on bone mineral content in young and adult rats: a comparative study. Eur J Pharmacol. 720(1-3):1-6.
• Hermizi H, Faizah O, Ima-Nirwana S, Ahmad Nazrun S, Norazlina M. 2009. Beneficial effects of tocotrienol and tocopherol on bone histomorphometric parameters in sprague-dawley male rats after nicotine cessation. Calcif Tissue Int. 84(1):65-74.
• Hosseinzadeh A, Thompson PR, Segal BH, Urban CF. 2016. Nicotine induces neutrophil extracellular traps. J Leukoc Biol. 100(5):1105-1112.
• Junqueira LC, Carneiro J. 2005. Junqueira's basic histology: text and atlas (11th ed). New York (NY): McGraw-Hill Education.
• Khaksary Mahabady M, Najafzadeh Varzi H, Zareyan Jahromi S. 2015. L-Carnitine protect against cyclophosphamide induced skeletal and neural tube malformations in rat fetuses. Acta Med Iran. 53(11):703-710.
• Kurtoglu S, Gunes T, Koklu E, Bastug O, Canoz O, Kula M, Bastug F, Gunes I. 2007. Influence of maternal nicotine exposure on neonatal rat bone: protective effect of pentoxifylline. Exp Biol Med (Maywood). 232(3):398-405.
• Mène-Saffrané L, DellaPenna D. 2010. Biosynthesis, regulation and functions of tocochromanols in plants. Plant Physiol Biochem. 48(5):301-309.
• Mitchell JA, Hammer RE. 1985. Effects of nicotine on oviducal blood flow and embryo development in the rat. J Reprod Fertil. 74(1):71-76.
• Mizrak S, Turan V, Caglayan O, Ercan G. 2015. The effect of long term pre/postnatal low/high dose nicotine exposure on tissue oxidant/antioxidant status and DNA damage in rats. Drug Res (Stuttg). 65(8):432-436.
• Muhammad N, Luke DA, Shuid AN, Mohamed N, Soelaiman IN. 2012. Two different isomers of vitamin e prevent bone loss in postmenopausal osteoporosis rat model. Evid Based Complement Alternat Med. 2012:161527.
• Norazlina M, Lee PL, Lukman HI, Nazrun AS, Ima-Nirwana S. 2007. Effects of vitamin E supplementation on bone metabolism in nicotine-treated rats. S Singapore Med J. 48(3):195-9.
• Oruc Ş. 1996. The effects of nicotine given during pregnancy in rats on molar teeth in neonatal period. [master’s thesis]. Diyarbakır: Dicle University.
• Pehlivan S, Uysal MA, Aydin PC, Pehlivan M, Nursal AF, Yavuzlar H, Kurnaz S, Sever U, Yavuz FK, Uysal S, et al. 2017. eNOS and XRCC4 VNTR variants contribute to formation of nicotine dependence and/or schizophrenia. Bratisl Lek Listy. 118(8):467-471.
• Radzi NFM, Ismail NAS, Alias E. 2018. Tocotrienols regulate bone loss through suppression on osteoclast differentiation and activity: a systematic review. Curr Drug Targets. 19(9):1095-1107.
• Sbrana E, Suter MA, Abramovici AR, Hawkins HK, Moss JE, Patterson L, Shope C, Aagaard-Tillery K. 2011. Maternal tobacco use is associated with increased markers of oxidative stress in the placenta. Am J Obstet Gynecol. 205(3):246.e1-7.
• Soysa H, Unur E, Düzler A, Karaca Ö, Ekinci N. 2011. Effects of intraperitoneal administration of the phenytoin on the skeletal system of rat fetus. Seizure. 20(3):187-193. Uçar I, Ertekin T, Nisari M, Ceylan D, Al Ö, Ülger H. 2016. The potential teratogenic effects of interferon beta-1a and interferon beta-1b on in vitro embryonic development. Folia Morphol (Warsz). 75(2):257-263.
• Xiao D, Wang L, Huang X, Li Y, Dasgupta C, Zhang L. 2016. Protective effect of antenatal antioxidant on nicotine-induced heart ischemia-sensitive phenotype in rat offspring. PLoS One. 11(2):e0150557.
• Yazıcı ZT. 2001. Effects of nicotine administration on prenatal palate development and craniofacial ossification of rat fetuses [dissertation]. İstanbul: Istanbul University.
• Yılmaz H, Ertekin T, Atay E, Nisari M, Susar Güler H, Al Ö, Payas A, Yılmaz S. 2018. Antioxidant role of melatonin against nicotine's teratogenic effects on embryonic bone development. Iran J Basic Med Sci. 21(8):787-793.
• Yilmaz S, Ozden B, Bas B, Altun G, Altunkaynak BZ. 2017. Could calcified triglyceride bone cement be an alternative graft material in maxillary sinus augmentation?. J Craniofac Surg. 28(1):97-103.
• Yoon V, Maalouf NM, Sakhaee K. 2012. The effects of smoking on bone metabolism. Osteoporos Int. 23(8):2081–2092.
• Yu F, Zheng A, Qian J, Li Y, Wu L, Yang J, Gao X. 2016. Prenatal nicotine exposure results in the myocardial fibrosis in the adult male offspring rats. Exp Toxicol Pathol. 68(8):445-450.